Please use this identifier to cite or link to this item:
|Type:||Artigo de periódico|
|Title:||N-ras Gene Point Mutations In Brazilian Acute Myelogenous Leukemia Patients Correlate With A Poor Prognosis.|
|Author:||De Melo, M B|
Lima, C S
Saad, S T
Costa, F F
|Abstract:||The frequency of ras gene mutations varies from 11 to 27% in AML populations from the United States and Europe but it seems that there is no study regarding the frequency of mutated N-ras gene in patients with AML in South America. In order to study the frequency of N-ras gene mutations (exons 1 and 2) in Brazilian patients with AML and to evaluate the possible correlation between the presence of the mutation and clinical features, 40 patients were analyzed. N-ras mutations were identified in DNA samples from eight of 40 AML patients (20%). No significant correlation was found between N-ras mutation and age, sex, race, response to therapy, FAB subtype or occupational exposure. However, the overall survival and AML-free survival were significantly shorter in patients with N-ras mutations than in those without these abnormalities.|
Aged, 80 And Over
Continental Population Groups
|Citation:||Leukemia & Lymphoma. v. 24, n. 3-4, p. 309-17, 1997-Jan.|
|Appears in Collections:||Unicamp - Artigos e Outros Documentos|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.